-
Signature
-
/s /Drew Parkes, Attorney-in-Fact for Belsky Scott
-
Issuer symbol
-
TEAM
-
Transactions as of
-
01 Oct 2025
-
Net transactions value
-
+$239,752
-
Form type
-
4
-
Filing time
-
02 Oct 2025, 17:54:20 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Belsky Scott |
Director |
C/O ATLASSIAN CORPORATION, 350 BUSH STREET, FLOOR 13, SAN FRANCISCO |
/s /Drew Parkes, Attorney-in-Fact for Belsky Scott |
02 Oct 2025 |
0001674730 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
TEAM |
Class A Common Stock |
Purchase |
$31,016 |
+200 |
+14% |
$155.08 |
1,655 |
01 Oct 2025 |
See Footnote |
F1, F2, F3 |
| transaction |
TEAM |
Class A Common Stock |
Purchase |
$45,244 |
+300 |
+18% |
$150.81 |
1,955 |
01 Oct 2025 |
See Footnote |
F1, F3, F4 |
| transaction |
TEAM |
Class A Common Stock |
Purchase |
$32,228 |
+200 |
+10% |
$161.14 |
2,155 |
01 Oct 2025 |
See Footnote |
F1, F3, F5 |
| transaction |
TEAM |
Class A Common Stock |
Purchase |
$15,949 |
+100 |
+4.6% |
$159.49 |
2,255 |
01 Oct 2025 |
See Footnote |
F1, F3 |
| transaction |
TEAM |
Class A Common Stock |
Purchase |
$30,495 |
+200 |
+8.9% |
$152.48 |
2,455 |
01 Oct 2025 |
See Footnote |
F1, F3, F6 |
| transaction |
TEAM |
Class A Common Stock |
Purchase |
$84,820 |
+566 |
+23% |
$149.86 |
3,021 |
01 Oct 2025 |
See Footnote |
F1, F3, F7 |
| holding |
TEAM |
Class A Common Stock |
|
|
|
|
|
1,634 |
01 Oct 2025 |
Direct |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: